Table 1.
Clinical, histological and therapeutic parameters of the patients
| Number of cases | Percentage (%) | |
|---|---|---|
| Sex | ||
| Male | 10 | 62 |
| Female | 6 | 37 |
| Age | ||
| >60 years | 25 | |
| ≤ 60 years | 12 | 75 |
| Stage | ||
| I | 2 | 12 |
| II | 3 | 19 |
| III | 0 | 0 |
| IV | 8 | 50 |
| Uncertain | 3 | 19 |
| Histology (WHO classification) | ||
| Diffuse follicular center | 1 | 6 |
| T cell rich B cell | 1 | 6 |
| Diffuse large cell | 10 | 62 |
| Precursor B lymphoblastic leukemia/lymphoma | 1 | 6 |
| Hodgkin’s disease (mixed cellularity) | 1 | 6 |
| Peripheral T cell, not otherwise specified | 1 | 6 |
| Unspecified | 1 | 6 |
| Cell type | ||
| T cell | 1 | 6 |
| B cell | 14 | 88 |
| Unspecified | 1 | 6 |
| International Prognostic Index score | ||
| Low (0–1) | 4 | 25 |
| Low intermediate (2) | 5 | 31 |
| High intermediate (3) | 0 | 0 |
| High (4–5) | 4 | 25 |
| Unknown | 3 | 18 |
| Therapy | ||
| Chemotherapy only | 3 | 18 |
| Radiotherapy and chemotherapy | 8 | 50 |
| Radiotherapy only | 0 | 0 |
| Surgery, radiotherapy and chemotherapy | 2 | 12 |
| No treatment | 3 | 18 |
| Response to therapy | ||
| Complete remission | 7 | 53 |
| Partial remission | 3 | 23 |
| No response | 3 | 23 |